- Home
- Publications
- Publication Search
- Publication Details
Title
Genetics of platelet inhibitor treatment
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Volume 77, Issue 4, Pages 642-653
Publisher
Wiley
Online
2013-08-28
DOI
10.1111/bcp.12230
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of CYP2C19*2 and *17 Genetic Variants on Platelet Response to Clopidogrel and Prasugrel Maintenance Dose and Relation to Bleeding Complications
- (2013) Charlotte Grosdidier et al. AMERICAN JOURNAL OF CARDIOLOGY
- ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
- (2012) et al. EUROPEAN HEART JOURNAL
- CYP2C19*2 and *17 Alleles Have a Significant Impact on Platelet Response and Bleeding Risk in Patients Treated With Prasugrel After Acute Coronary Syndrome
- (2012) Thomas Cuisset et al. JACC-Cardiovascular Interventions
- 2012 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update)
- (2012) Hani Jneid et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Influence of the paraoxonase-1 Q192R genetic variant on clopidogrel responsiveness and recurrent cardiovascular events: a systematic review and meta-analysis
- (2012) J.-L. RENY et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Point-of-care genetic testing for personalisation of antiplatelet treatment (RAPID GENE): a prospective, randomised, proof-of-concept trial
- (2012) Jason D Roberts et al. LANCET
- The influence of CYP2C19*2 and *17 on on-treatment platelet reactivity and bleeding events in patients undergoing elective coronary stenting
- (2012) Ankie M. Harmsze et al. Pharmacogenetics and Genomics
- The functional G143E variant of carboxylesterase 1 is associated with increased clopidogrel active metabolite levels and greater clopidogrel response
- (2012) Joshua P. Lewis et al. Pharmacogenetics and Genomics
- 2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
- (2011) Jeffrey L. Anderson et al. CIRCULATION
- Paraoxonase-1 Q192R Polymorphism and Antiplatelet Effects of Clopidogrel in Patients Undergoing Elective Coronary Stent Placement
- (2011) Dietmar Trenk et al. Circulation-Cardiovascular Genetics
- Effect of Paraoxonase-1 Polymorphism on Clinical Outcomes in Patients Treated With Clopidogrel After an Acute Myocardial Infarction
- (2011) T Simon et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Paraoxonase 1 (PON1) Gene Variants Are Not Associated With Clopidogrel Response
- (2011) J P Lewis et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
- (2011) et al. EUROPEAN HEART JOURNAL
- No association of paraoxonase-1 Q192R genotypes with platelet response to clopidogrel and risk of stent thrombosis after coronary stenting
- (2011) D. Sibbing et al. EUROPEAN HEART JOURNAL
- Meta-analyses of the association between cytochrome CYP2C19 loss- and gain-of-function polymorphisms and cardiovascular outcomes in patients with coronary artery disease treated with clopidogrel
- (2011) Michel Zabalza et al. HEART
- High Doses of Clopidogrel to Overcome Genetic Resistance
- (2011) Jean-Philippe Collet et al. JACC-Cardiovascular Interventions
- Dosing Clopidogrel Based on CYP2C19 Genotype and the Effect on Platelet Reactivity in Patients With Stable Cardiovascular Disease
- (2011) Jessica L. Mega et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clopidogrel–Drug Interactions
- (2011) Eric R. Bates et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Relationship between paraoxonase-1 activity, its Q192R genetic variant and clopidogrel responsiveness in the ADRIE study
- (2011) P. FONTANA et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- The gain-of-function variant allele CYP2C19*17: a double-edged sword between thrombosis and bleeding in clopidogrel-treated patients
- (2011) Y. LI et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Paraoxonase-1 and clopidogrel efficacy
- (2011) Patrick M Dansette et al. NATURE MEDICINE
- Impact of genetic variants on post-clopidogrel platelet reactivity in patients after elective percutaneous coronary intervention
- (2011) Orsolya Rideg et al. PHARMACOGENOMICS
- ABCB1 C3435T polymorphism and risk of adverse clinical events in clopidogrel treated patients: A meta-analysis
- (2011) Man Luo et al. THROMBOSIS RESEARCH
- Cytochrome 2C19*17 Allelic Variant, Platelet Aggregation, Bleeding Events, and Stent Thrombosis in Clopidogrel-Treated Patients With Coronary Stent Placement
- (2010) Dirk Sibbing et al. CIRCULATION
- First Analysis of the Relation Between CYP2C19 Genotype and Pharmacodynamics in Patients Treated With Ticagrelor Versus Clopidogrel
- (2010) Udaya S. Tantry et al. Circulation-Cardiovascular Genetics
- Absorption, Distribution, Metabolism, and Excretion of Ticagrelor in Healthy Subjects
- (2010) R. Teng et al. DRUG METABOLISM AND DISPOSITION
- Reduced-Function CYP2C19 Genotype and Risk of Adverse Clinical Outcomes Among Patients Treated With Clopidogrel Predominantly for PCI
- (2010) Jessica L. Mega et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Consensus and Future Directions on the Definition of High On-Treatment Platelet Reactivity to Adenosine Diphosphate
- (2010) Laurent Bonello et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Clopidogrel Loading Dose Adjustment According to Platelet Reactivity Monitoring in Patients Carrying the 2C19*2Loss of Function Polymorphism
- (2010) Laurent Bonello et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Impact of Cytochrome P450 2C19 Loss-of-Function Polymorphism and of Major Demographic Characteristics on Residual Platelet Function After Loading and Maintenance Treatment With Clopidogrel in Patients Undergoing Elective Coronary Stent Placement
- (2010) Willibald Hochholzer et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Isolated and interactive impact of common CYP2C19 genetic variants on the antiplatelet effect of chronic clopidogrel therapy
- (2010) D. SIBBING et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON–TIMI 38 trial: a pharmacogenetic analysis
- (2010) Jessica L Mega et al. LANCET
- Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial
- (2010) Lars Wallentin et al. LANCET
- Paraoxonase-1 is a major determinant of clopidogrel efficacy
- (2010) Heleen J Bouman et al. NATURE MEDICINE
- A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function
- (2009) King Leung Fung et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Cytochrome P450 Genetic Polymorphisms and the Response to Prasugrel
- (2009) Jessica L. Mega et al. CIRCULATION
- A Possible Mechanism for the Differences in Efficiency and Variability of Active Metabolite Formation from Thienopyridine Antiplatelet Agents, Prasugrel and Clopidogrel
- (2009) K. Hagihara et al. DRUG METABOLISM AND DISPOSITION
- Identification of the Human Cytochrome P450 Enzymes Involved in the Two Oxidative Steps in the Bioactivation of Clopidogrel to Its Pharmacologically Active Metabolite
- (2009) M. Kazui et al. DRUG METABOLISM AND DISPOSITION
- Cytochrome P450 2C19 loss-of-function polymorphism and stent thrombosis following percutaneous coronary intervention
- (2009) D. Sibbing et al. EUROPEAN HEART JOURNAL
- Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy
- (2009) Alan R. Shuldiner JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Metabolism and Disposition of the Thienopyridine Antiplatelet Drugs Ticlopidine, Clopidogrel, and Prasugrel in Humans
- (2009) Nagy A. Farid et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Platelet Reactivity After Clopidogrel Treatment Assessed With Point-of-Care Analysis and Early Drug-Eluting Stent Thrombosis
- (2009) Dirk Sibbing et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The CYP2C19*17 allele is associated with better platelet response to clopidogrel in patients admitted for non-ST acute coronary syndrome
- (2009) C. FRÉRE et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Ticagrelor binds to human P2Y12independently from ADP but antagonizes ADP-induced receptor signaling and platelet aggregation
- (2009) J. J. J. VAN GIEZEN et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
- (2009) Lars Wallentin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Two CES1 Gene Mutations Lead to Dysfunctional Carboxylesterase 1 Activity in Man: Clinical Significance and Molecular Basis
- (2008) Hao-Jie Zhu et al. AMERICAN JOURNAL OF HUMAN GENETICS
- The Pharmacogenetics and Pharmacodynamics of Clopidogrel Response
- (2008) Patrick Gladding et al. JACC-Cardiovascular Interventions
- Cytochrome P450 2C19 681G>A Polymorphism and High On-Clopidogrel Platelet Reactivity Associated With Adverse 1-Year Clinical Outcome of Elective Percutaneous Coronary Intervention With Drug-Eluting or Bare-Metal Stents
- (2008) Dietmar Trenk et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study
- (2008) Jean-Philippe Collet et al. LANCET
- Cytochrome P-450 Polymorphisms and Response to Clopidogrel
- (2008) Jessica L. Mega et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetic Determinants of Response to Clopidogrel and Cardiovascular Events
- (2008) Tabassome Simon et al. NEW ENGLAND JOURNAL OF MEDICINE
- CYP2C19 and nongenetic factors predict poor responsiveness to clopidogrel loading dose after coronary stent implantation
- (2008) Tobias Geisler et al. PHARMACOGENOMICS
- Impaired bioavailability of clopidogrel in patients with a ST-segment elevation myocardial infarction
- (2008) Antonius A.C.M. Heestermans et al. THROMBOSIS RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started